NF-kappaB/NN
functions/VBZ
as/IN
both/CC
a/DT
proapoptotic/JJ
and/CC
antiapoptotic/JJ
regulatory/JJ
factor/NN
within/IN
a/DT
single/JJ
cell/NN
type/NN
./.

Recently/RB
NF-kappaB/NN
has/VBZ
been/VBN
shown/VBN
to/TO
have/VB
both/CC
proapoptotic/JJ
and/CC
antiapoptotic/JJ
functions/NNS
./.
=====
In/IN
T/NN
cell/NN
hybridomas/NNS
,/,
both/CC
T/NN
cell/NN
activators/NNS
and/CC
glucocorticoids/NNS
induce/VBP
apoptosis/NN
./.
=====
Here/RB
we/PRP
show/VBP
that/IN
blockade/NN
of/IN
NF-kappaB/NN
activity/NN
,/,
using/VBG
a/DT
dominant/JJ
negative/JJ
IkappaBalpha/NN
,/,
has/VBZ
opposite/JJ
effects/NNS
on/IN
these/DT
two/CD
apoptotic/JJ
signals/NNS
./.
=====
Treatment/NN
with/IN
PMA/NN
plus/CC
ionomycin/NN
(/(
P/I/NN
)/)
results/VBZ
in/IN
the/DT
upregulation/NN
of/IN
Fas/NN
Ligand/NN
(/(
FasL/NN
)/)
and/CC
induction/NN
of/IN
apoptosis/NN
./.
=====
Inhibition/NN
of/IN
NF-kappaB/NN
activity/NN
inhibits/VBZ
the/DT
P/I/NN
mediated/JJ
induction/NN
of/IN
FasL/NN
mRNA/NN
and/CC
decreases/VBZ
the/DT
level/NN
of/IN
apoptosis/NN
in/IN
these/DT
cultures/NNS
,/,
thus/RB
establishing/VBG
NF-kappaB/NN
as/IN
a/DT
proapoptotic/JJ
factor/NN
in/IN
this/DT
context/NN
./.
=====
Conversely/RB
,/,
inhibition/NN
of/IN
NF-kappaB/NN
confers/VBZ
a/DT
tenfold/JJ
increase/NN
in/IN
glucocorticoid/NN
mediated/JJ
apoptosis/NN
,/,
establishing/VBG
that/IN
NF-kappaB/NN
also/RB
functions/VBZ
as/IN
an/DT
antiapoptotic/JJ
factor/NN
./.
=====
We/PRP
conclude/VBP
that/IN
NF-kappaB/NN
is/VBZ
a/DT
context-dependent/JJ
apoptosis/NN
regulator/NN
./.
=====
Our/PRP$
data/NN|NNS
suggests/VBZ
that/IN
NF-kappaB/NN
may/MD
function/VB
as/IN
an/DT
antiapoptotic/JJ
factor/NN
in/IN
thymocytes/NNS
while/IN
functioning/VBG
as/IN
a/DT
proapoptotic/JJ
factor/NN
in/IN
mature/JJ
peripheral/JJ
T/NN
cells/NNS
./.